ALNYLAM PHARMACEUTICALS, INC. Debt Securities, Available-for-sale, Noncurrent
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Debt Securities, Available-for-sale, Noncurrent of $648.00 thousand as of 2018-03-31, per its 10-Q filed 2018-05-04.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2019-02-14
- 2018-03-31: Debt Securities, Available-for-sale, Noncurrent $648.00K.
- 2017-12-31: Debt Securities, Available-for-sale, Noncurrent $13.92M.
- 2017-09-30: Debt Securities, Available-for-sale, Noncurrent $51.54M.
- 2017-06-30: Debt Securities, Available-for-sale, Noncurrent $174.57M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2018-03-31 | $648.00K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $13.92M 10-K · filed 2019-02-14 |
| 2017-09-30 | $51.54M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $174.57M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $255.31M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $324.80M 10-K · filed 2018-02-15 |
| 2016-09-30 | $339.57M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $287.23M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $228.59M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $251.84M 10-K · filed 2017-02-15 |
| 2015-09-30 | $358.63M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $456.80M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $483.77M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $279.82M 10-K · filed 2016-02-12 |
| 2014-09-30 | $324.53M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $350.58M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $335.02M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $104.60M 10-K · filed 2015-02-13 |
| 2013-09-30 | $173.37M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $169.82M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $103.42M 10-K · filed 2014-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |